Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Pfizer Oncology - Building a new paradigm in prostate cancer

Expanding the potential of PARP inhibitors

Date

14 Sep 2020

Session

Pfizer Oncology - Building a new paradigm in prostate cancer

Presenters

Joaquin Mateo

Authors

J. Mateo

Author affiliations

  • Vall d'Hebron University Hospital, 8035 - Barcelona/ES
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings